Skip to main content
Search form
Search
Subscribe to newsletter +
European Association of Hospital Pharmacists
Menu
Main menu
Home
About Us
Who we are
Board
Staff
Students
Transparency
Contact Information
Call for Expressions of Interest
Members
Associate membership
News
Press Releases
EAHP Newsletters
EAHP in the news
Multimedia Gallery
Events
Calendar
Academy
Synergy Masterclass
EAHP BOOST
Congresses
General Assemblies
Accreditations
EAHP Synergy Certification Courses
Open Learning
Get Involved
Sponsors and partners
HP Practice
EAHP COVID-19 Resource Centre
European Statements of Hospital Pharmacy
What hospital pharmacists do
EAHP-ESCP Oath to Society
FIP global statements
National legislation on hospital pharmacy
Good Practice Initiatives
Common training framework
Environmental Sustainability
European Council for Pharmacy Education Accreditation
Investigation of the hospital pharmacy profession in Europe
Hospital Pharmacy Day
SIGs
Controlled Substances Management
Special Interest Group on Investigation of medication errors and efficiency in oncology
Automated Medication Management
Working Towards Eliminating Avoidable Harm
Hazardous Medicinal Products
Hospital Pharmacist’s Preparedness for in-vivo gene therapy medicinal products
Investigation of Medication Errors in Intensive Care Units
Use of Prefilled Syringes in Intensive Care Units and Operating Theaters
Policy
Resources
Consultations
Position Papers
Get involved and keep up to date
Access to Medicines
Ageing society
Infectious Diseases and AMR
ATMPs
Bar coding medicines to the single unit
Biosimilar medicines
Clinical trials
Digital Health
EMA - EAHP collaboration
European List of Emergency Medicines
Falsified Medicines
Hazardous Medicinal Products
Hospital Pharmacy Specialisation
Medical device regulation
Medicines shortages
Patient safety
Pharmaceuticals in the environment
Pharmacy preparations and compounding
Procurement
Public spending austerity
SmPC
Vaccination
Workforce
Statements
GPIs
Publications
2019 EP Election Manifesto
General information
EAHP Annual report
European Journals of Hospital Pharmacy
EAHP Surveys of HP practice
EAHP History Book
Practical Pharmaceutics
Congress presentation webcasts
2024 European Parliament Election Manifesto
Member Center
You are here
Home
Drug Information and Pharmacotherapy
DI-057
UTILITY OF A NEW TOOL TO GUIDE DEPRESCRIBING IN CHRONIC PATIENTS: A CHART REVIEW
DI-056
LINEZOLID INDUCED THROMBOCYTOPENIA IN A PATIENT WITH RENAL INSUFFICIENCY: A CASE REPORT AND A RETROSPECTIVE CASE STUDY
DI-055
EVALUATION OF TOCILIZUMAB RESPONSE IN RHEUMATOID ARTHRITIS. COMPARISION OF THE RESULTS WITH THE CLINICAL TRIAL
DI-054
SAFETY RESULTS OF DIRECT ACTING ANTIVIRALS FOR THE TREATMENT OF HEPATITIS C VIRUS INFECTION
DI-053
ADHERENCE, QUALITY OF LIFE AND PATIENT SATISFACTION WITH DALFAMPRIDINE IN CLINICAL PRACTICE
DI-051
TOLVAPTAN OFF-LABEL USE IN HYPONATRAEMIA DUE TO HEART FAILURE. A CASE SERIES
DI-050
COMPARATIVE STUDY OF QUALITY INDICATORS OF PRESCRIPTION AT HOSPITALS IN A PUBLIC HEALTHCARE SYSTEM
DI-049
DURATION OF NATALIZUMAB MAINTENANCE IN PATIENTS WITH MULTIPLE SCLEROSIS
DI-048
PHARMACEUTICAL CARE PROGRAMME IN FERTILITY TREATMENTS: ANALYSIS OF PATIENT SATISFACTION LEVELS
DI-047
HIGH RISK MEDICATION: ANALYSIS OF KCL ADMINISTRATION
DI-046
DIFFERENCES IN TREATMENT DURATION IN PANCREATIC CANCER PATIENTS TREATED WITH CHEMOTHERAPY FROM 2005 TO 2014
DI-044
INAPPROPIATE USE OF OSELTAMIVIR IN HOSPITALISED PATIENTS
DI-043
EVALUATION OF THERAPEUTIC ADHERENCE AND RELATED FACTORS IN PATIENTS AFFECTED BY MULTIPLE SCLEROSIS
DI-042
MANAGEMENT OF LIPOSOMAL ANTHRACYCLINE EXTRAVASATIONS: USE OF DESRAZOXANE
DI-041
DESIGN OF A METHODOLOGY FOR CULTURAL TRANSLATION AND ADAPTATION OF THE ADHERENCE TO REFILLS AND MEDICATIONS SCALE (ARMS)
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »
Follow Us